Developmental expression of HNK-1-reactive antigens in the rat cerebellum and localization of sulfoglucuronyl glycolipids in molecular layer and deep cerebellar nuclei.
Monoclonal antibody HNK-1-reactive carbohydrate epitope is expressed on proteins, proteoglycans, and sulfoglucuronyl glycolipids (SGGLs). The developmental expression of these HNK-1-reactive antigens was studied in rat cerebellum. The expression of sulfoglucuronyl lacto-N-neotetraosylceramide (SGGL-1) was biphasic with an initial maximum at postnatal day one (PD 1), followed by a second rise in the level at PD 20. The level of sulfoglucuronyl lacto-N-norhexaosyl ceramide (SGGL-2) in cerebellum was low until PD 15 and then increased to a plateau at PD 20. The levels of SGGLs increased during postnatal development of the cerebellum, contrary to their diminishing expression in the cerebral cortex. The expression of HNK-1-reactive glycoproteins decreased with development of the rat cerebellum from PD 1. Several HNK-1-reactive glycoproteins with apparent molecular masses between 150 and 325 kDa were visualized between PD 1 and PD 10. However, beyond PD 10, only two HNK-1-reactive bands at 160 and 180 kDa remained. The latter appeared to be neural cell adhesion molecule, N-CAM-180. A diffuse HNK-1-reactive band seen at the top of polyacrylamide electrophoretic gels was due mostly to proteoglycans. This band increased in its reactivity to HNK-1 between PD 15 and PD 25 and then decreased in the adult cerebellum. The lipid antigens were shown by two complementary methodologies to be localized primarily in the molecular layer and deep cerebellar nuclei as opposed to the granular layer and white matter. A fixation procedure which eliminates HNK-1-reactive epitope on glycoproteins and proteoglycans, but does not affect glycolipids, allowed selective immunoreactivity in the molecular layer and deep cerebellar nuclei.(ABSTRACT TRUNCATED AT 250 WORDS)
Eunice Kennedy Shriver Center for Mental Retardation, Waltham, MA 02254.
N
N
Prasadaro
O
O
Koul
S A
SA
Tobet
D K
DK
Chou
F B
FB
Jungalwala
D000818:Animals; D000831:Animals, Newborn; D000911:Antibodies, Monoclonal; D000943:Antigens, Differentiation / Q000276:immunology*; D018959:CD57 Antigens; D015816:Cell Adhesion Molecules, Neuronal / Q000378:metabolism; D002529:Cerebellar Nuclei / Q000378:metabolism*; D002531:Cerebellum / Q000254:growth & development / Q000276:immunology* / Q000378:metabolism; D005915:Globosides / Q000378:metabolism*; D006651:Histocytochemistry; D007150:Immunohistochemistry; D051381:Rats; D011919:Rats, Inbred Strains
D000911:Antibodies, Monoclonal; D000943:Antigens, Differentiation; D018959:CD57 Antigens; D015816:Cell Adhesion Molecules, Neuronal; D005915:Globosides; C063678:3-sulfoglucuronyl-lacto-N-neotetraosylceramide; C063679:3-sulfoglucuronyl-lacto-N-norhexaosylceramide